Enzyme replacement market to grow 6.5% per year until 2028

A new report from Future Market Insights (FMI) suggests that the global enzyme replacement therapy market is likely to to expand by 6.5% compound annual growth until over the next 10 years.

FMI expects enzyme replacement therapies to generate more than $13.7 billion each year by 2028 and singles out the Asia-Pacific region, in particular China, as being a key driver in this market expansion thanks to rapid improvement in standards of healthcare.

Enzyme replacement therapies are used in a number of chronic disease indications, including Fabry disease, Gaucher disease, Hunter syndrome and Pompe disease. The most lucrative of indications, FMI says, is mucopolysaccharidosis.